NEW DELHI: On October 27, the Supreme Court reserved its verdict on two public interest petitions that ask how medicines are priced in India — one filed in 2023 by advocate Kishan Chand Jain, the other by Dr Sanjay Kulshrestha. They seek control of launch prices, mandatory generic prescribing and margin caps on medical devices….
…
A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.
Quick Links
Get important news delivered directly to your inbox and stay connected!